本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
盤後5.29-0.0300-0.56%18:35 EDT
成交量:5,995.92萬
成交額:3.37億
市值:23.10億
市盈率:-2.95
高:6.20
開:6.04
低:5.30
收:5.91
52周最高:12.36
52周最低:3.79
股本:4.34億
流通股本:4.15億
量比:1.14
換手率:14.45%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
淨資產收益率:-86.34%
總資產收益率:-39.08%
市淨率:2.51
市盈率(LYR):-3.15

資料載入中...

2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]